Neurocrine Biosciences
The Director, New Product Commercialization provides commercial strategy and input across Neurocrine's portfolio and pipeline, guiding product and portfolio assessments from early pre-clinical development through early phase 3. The role supports business development, lifecycle strategy, and launch planning across multiple therapeutic areas and modalities, and leads commercial insights across development stage gates to inform clinical and commercial decision-making.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Senior Manager Strategic Marketing - Immuno-Oncology
Digital Biology
Sr Director, Commercial Product Strategy
Gilead Sciences
Director New Product Commercialization New Wave United States
alnylam
New Product Planning Associate Director - Biopharma
Sumitomo Pharma America, Inc.
Director Market Research Value Pipeline Commercialization Vpc United States
alnylam
Associate Director, Early Commercial Strategy
AstraZeneca